Your browser doesn't support javascript.
Analysis of COVID-19 mRNA Vaccine-induced Mouth Ulcers Using the Japanese Adverse Drug Event Report Database.
Onoda, T; Tanaka, H; Matsuo, H; Takigawa, M; Satoh, M; Ishii, T.
  • Onoda T; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba.
  • Tanaka H; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba;, Email: hiroyuki.tanaka@phar.toho-u.ac.jp.
  • Matsuo H; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba; Clinical Development Department, Daiichi Sankyo Co., Ltd., Tokyo.
  • Takigawa M; Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital, Tokyo.
  • Satoh M; Department of Toxicology and Pharmacology, Division of Pharmacy Practice, Meiji Pharmaceutical University, Tokyo, Japan.
  • Ishii T; Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba.
Pharmazie ; 78(5): 63-66, 2023 05 01.
Artículo en Inglés | MEDLINE | ID: covidwho-2317853
ABSTRACT
There are case reports of mouth ulcers caused by the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA) vaccine; however, the actual number and characteristics of cases are unknown. Therefore, we examined this issue using the Japanese Adverse Drug Event Report (JADER), a large Japanese database. We calculated the reported odds ratio (ROR) of drugs that may be specifically associated with mouth ulcers and assumed that a signal was present if the lower limit of the calculated ROR's 95% confidence interval (CI) was > 1. In addition, the time to symptom onset after administration of the COVID-19 mRNA and influenza HA vaccines was investigated. We found that the JADER database contained 4,661 mouth ulcer cases between April 2004 and March 2022. The COVID-19 mRNA vaccine was the eighth most common causative drug for mouth ulcers, with 204 reported cases. The ROR was 1.6 (95% CI, 1.4-1.9) and a signal was detected. There were 172 mouthulcer cases associated with the Pfizer-BioNTech's COVID-19 mRNA vaccine, 76.2% of which were female. The outcome was no unrecovered cases with the influenza HA vaccine, whereas the COVID-19 mRNA vaccine showed unrecovered cases (Pfizer-BioNTech 12.2%, Moderna 11.1%). The median time-to-onset of the mouth ulcers was two days for the COVID-19 mRNA vaccine and one day for the influenza HA vaccine, indicating that mouth ulcers caused by the COVID-19 mRNA vaccine were delayed adverse events. In this study, the COVID-19 mRNA vaccine was shown to cause mouth ulcers in a Japanese population.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Úlceras Bucales / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Gripe Humana / COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico Tópicos: Vacunas Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Pharmazie Asunto de la revista: Farmacia Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Úlceras Bucales / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Gripe Humana / COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico Tópicos: Vacunas Límite: Femenino / Humanos / Masculino Idioma: Inglés Revista: Pharmazie Asunto de la revista: Farmacia Año: 2023 Tipo del documento: Artículo